IC 35-48-1.1-8 — "Controlled substance analog"
Chapter 1.1. Definitions
Bills amending this section
Bills citing this section
- HB 10032026Signed into law
Boards and commissions.
- HB 10522026Signed into law
Various administrative law matters.
- SB 1852026Signed into law
Alcohol and tobacco matters.
- HB 10042026Signed into law
Various education matters.
- HB 12582026Signed into law
Crimes of violence.
- HB 12732026Signed into law
Requirements for proxy advisors.
- HB 10632026In committee
Deceptive consumer sales.
- HB 13242026In committee
Consumer pricing information.
- HB 11252026In committee
False or fraudulent deeds and affidavits.
- SB 862026In committee
Charter schools.
Section text
Sec. 8. (a) "Controlled substance analog" means a substance that, due to its chemical structure and potential for abuse or misuse, meets the following criteria: (1) The substance is substantially similar to a controlled substance classified under IC 35-48-2. (2) The substance has a narcotic, stimulant, depressant, or hallucinogenic effect on the central nervous system or is represented or intended to have a narcotic, stimulant, depressant, or hallucinogenic effect on the central nervous system substantially similar to or greater than that of a controlled substance classified under IC 35-48-2. (b) The definition set forth in subsection (a) does not include: (1) a controlled substance; (2) a legend drug; (3) a substance for which there is an approved new drug application; (4) any compound, mixture, or preparation that contains any controlled substance, that is not for administration to a human being or an animal, and that is packaged in a form or concentration, or with adulterants or denaturants, such that as packaged it does not present any significant potential for abuse; (5) a substance to which an investigational exemption applies under Section 505 of the federal Food, Drug and Cosmetic Act (chapter 675, 52 Stat. 1052 (21 U.S.C. 355)), but only to the extent that conduct with respect to the substance is pursuant to the exemption; or (6) low THC hemp extract. (c) For purposes of subsection (a), "substantially similar", as it applies to the chemical structure of a substance, means that the chemical structure of the substance, when compared to the structure of a controlled substance, has a single difference in the structural formula that substitutes one (1) atom or functional group for another, including: (1) one (1) halogen for another halogen; (2) one (1) hydrogen for a halogen; (3) one (1) halogen for a hydrogen; or (4) an alkyl group added or deleted: (A) as a side chain to or from a molecule; or (B) from a side chain of a molecule.
As added by P.L.186-2025, SEC.249.
Source: official publisher (2026 edition)